MTOR and renal cell carcinoma: Surgery is the main treatment for BHD complicated with RCC, and it has also been reported that the mechanistic target of rapamycin (mTOR) inhibitor everolimus can be used in the treatment of metastatic RCC,[3,4] but its efficacy evaluation requires further research.